Lisinopril/hydrochlorothiazide

Lisinopril/hydrochlorothiazide, sold under the trade name Zestoretic among others, is a combination of the medications lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic.[1] It is used to treat high blood pressure.[1] Typically, it becomes an option once a person is doing well on the individual components.[2] It is taken by mouth.[1]

Lisinopril/hydrochlorothiazide
Combination of
LisinoprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
Trade namesZestoretic, Prinzide, others
AHFS/Drugs.comMultum Consumer Information
MedlinePlusa601070
Pregnancy
category
  • US: D (Evidence of risk)
    Routes of
    administration    		By mouth
    ATC code
    Legal status
    Legal status
    • In general: ℞ (Prescription only)
      (verify)

    Common side effects include dizziness, headache, cough, and feeling tired.[3] Severe side effects may include angioedema and low blood pressure.[3] Use during pregnancy may harm the baby.[3]

    The combination was approved for medical use in the United States in 1989.[1] It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.[4] It is available as a generic medication.[2] In the United States the wholesale cost per dose is less than US$0.05 as of 2018.[5] In the United Kingdom it costs the NHS about GB£0.40 per dose as of 2017.[2] In 2017, it was the 44th most commonly prescribed medication in the United States, with more than 16 million prescriptions.[6][7]

    References
    1. "Hydrochlorothiazide and lisinopril Uses, Side Effects & Warnings". Drugs.com. Cerner Multum. Retrieved 26 December 2018.
    2. British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. 166. ISBN 978-0857112989.
    3. "Lisinopril and Hydrochlorothiazide - FDA prescribing information, side effects and uses". Drugs.com. Solco Healthcare LLC.
    4. World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
    5. "NADAC as of 2018-12-19". Centers for Medicare and Medicaid Services. Retrieved 22 December 2018.
    6. "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
    7. "Hydrochlorothiazide; Lisinopril - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.